Eli Lilly announced on Friday safety and efficacy results from two separate late-stage studies testing its approved drugs for ...
Discover how glucocorticoid-mediated eosinopoiesis in asthma creates a paradox, influencing relapse, steroid resistance, and ...
21hon MSN
Eli Lilly, Incyte post new late-stage trial data for Olumiant in adolescents with hair loss
Eli Lilly (LLY) stock and Incyte (INCY) stock in focus as the companies post new late-stage trial data for their hair loss ...
Thermo Fisher Scientific has introduced a new high-resolution mass spectrometry system designed specifically for ...
This expert-authored comprehensive application guide outlines the vital role of insulation in safe electrical products and ...
Elinzanetant provides a hormone-free treatment option for vasomotor symptoms by targeting the brain's thermoregulatory center ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results